![Jacinth Fairley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 2 M $ in data 31/08/2026
Jacinth K.
Fairley is currently Chairman at Baker Heart & Diabetes Institute and Independent Non-Executive Director at Mirrabooka Investments Ltd. since 2018.
Former roles include Chief Executive Officer, MD & Executive Director at Starpharma Holdings Ltd. from 2006 to 2024, Director at Melbourne Business School from 2010 to 2020, and Member of the Pharmaceutical Industry Working Group.
Education includes an MBA from Melbourne Business School and an undergraduate degree from the University of Melbourne.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 12/08/2025 | 4.145.686 ( 0,87% ) | 2 M $ | 31/08/2026 | |
| 21/08/2026 | 55.624 ( 0,02% ) | 101 651 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MIRRABOOKA INVESTMENTS LIMITED | Direttore/Membro del Consiglio | 15/02/2018 |
Baker Heart & Diabetes Institute
 Baker Heart & Diabetes Institute Miscellaneous Commercial ServicesCommercial Services Owns and operates medical research institutes | Presidente | - |
| Società | Posizione | Fine |
|---|---|---|
| STARPHARMA HOLDINGS LIMITED | Amministratore Delegato | 08/01/2024 |
Melbourne Business School
 Melbourne Business School Other Consumer ServicesConsumer Services Functions as a College/University | Direttore/Membro del Consiglio | 01/12/2020 |
Pharmaceutical Industry Working Group | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Melbourne Business School
Melbourne Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Starpharma Holdings Ltd.
 Starpharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of dendrimer products for pharmaceutical, life science & other applications | Health Technology |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mirrabooka Investments Ltd.
 Mirrabooka Investments Ltd. Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Pharmaceutical Industry Working Group | |
Baker Heart & Diabetes Institute
Baker Heart & Diabetes Institute Miscellaneous Commercial ServicesCommercial Services Owns and operates medical research institutes | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
